Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 May 1;41(3):323-342.
doi: 10.1093/femsre/fux012.

Perspectives for clinical use of engineered human host defense antimicrobial peptides

María Eugenia Pachón-Ibáñez  1 , Younes Smani  1 , Jerónimo Pachón  1   2 , Javier Sánchez-Céspedes  1   2
Affiliations
Review

Perspectives for clinical use of engineered human host defense antimicrobial peptides

María Eugenia Pachón-Ibáñez et al. FEMS Microbiol Rev. .

Abstract

Infectious diseases caused by bacteria, viruses or fungi are among the leading causes of death worldwide. The emergence of drug-resistance mechanisms, especially among bacteria, threatens the efficacy of all current antimicrobial agents, some of them already ineffective. As a result, there is an urgent need for new antimicrobial drugs. Host defense antimicrobial peptides (HDPs) are natural occurring and well-conserved peptides of innate immunity, broadly active against Gram-negative and Gram-positive bacteria, viruses and fungi. They also are able to exert immunomodulatory and adjuvant functions by acting as chemotactic for immune cells, and inducing cytokines and chemokines secretion. Moreover, they show low propensity to elicit microbial adaptation, probably because of their non-specific mechanism of action, and are able to neutralize exotoxins and endotoxins. HDPs have the potential to be a great source of novel antimicrobial agents. The goal of this review is to provide an overview of the advances made in the development of human defensins as well as the cathelicidin LL-37 and their derivatives as antimicrobial agents against bacteria, viruses and fungi for clinical use.

Keywords: antibacterial; antifungal; antiviral; cathelicidin; defensins; infectious diseases.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Mechanisms of action of human defensins and cathelicidins.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Achtman AH, Pilat S, Law CW et al. Effective adjunctive therapy by an innate defense regulatory peptide in a preclinical model of severe malaria. Sci Transl Med 2012;4:135ra164. - PubMed
    1. Adessi C, Soto C. Converting a peptide into a drug: strategies to improve stability and bioavailability. Curr Med Chem 2002;9:963–78. - PubMed
    1. Alekseeva L, Huet D, Femenia F et al. Inducible expression of beta defensins by human respiratory epithelial cells exposed to Aspergillus fumigatus organisms. BMC Microbiol 2009;9:33. - PMC - PubMed
    1. Arlen PA, Falconer R, Cherukumilli S et al. Field production and functional evaluation of chloroplast-derived interferon-alpha2b. Plant Biotechnol J 2007;5:511–25. - PMC - PubMed
    1. Arlen PA, Singleton M, Adamovicz JJ et al. Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts. Infect Immun 2008;76:3640–50. - PMC - PubMed